113 related articles for article (PubMed ID: 9523687)
21. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
Chung HW; Wen Y; Ahn JJ; Moon HS; Polan ML
J Clin Endocrinol Metab; 2001 Mar; 86(3):1332-40. PubMed ID: 11238529
[TBL] [Abstract][Full Text] [Related]
23. Blockage of the urokinase receptor on the cell surface: construction and characterization of a hybrid protein consisting of the N-terminal fragment of human urokinase and human albumin.
Lu H; Yeh P; Guitton JD; Mabilat C; Desanlis F; Maury I; Legrand Y; Soria J; Soria C
FEBS Lett; 1994 Dec; 356(1):56-9. PubMed ID: 7988721
[TBL] [Abstract][Full Text] [Related]
24. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.
Reuning U; Magdolen V; Hapke S; Schmitt M
Biol Chem; 2003 Aug; 384(8):1119-31. PubMed ID: 12974381
[TBL] [Abstract][Full Text] [Related]
25. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
26. The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis.
Alfano D; Franco P; Vocca I; Gambi N; Pisa V; Mancini A; Caputi M; Carriero MV; Iaccarino I; Stoppelli MP
Thromb Haemost; 2005 Feb; 93(2):205-11. PubMed ID: 15711734
[TBL] [Abstract][Full Text] [Related]
27. [Urokinase plasminogen activator (u-PA) and urokinase type plasminogen activator receptor (u-PAR) in children with ulcerative colitis].
Grabarczyk E; Szaflarska-Popławska A; Góralczyk K; Adamska I; Rość D
Med Wieku Rozwoj; 2007; 11(1):41-4. PubMed ID: 17965463
[TBL] [Abstract][Full Text] [Related]
28. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.
Kroon ME; Koolwijk P; van Goor H; Weidle UH; Collen A; van der Pluijm G; van Hinsbergh VW
Am J Pathol; 1999 Jun; 154(6):1731-42. PubMed ID: 10362798
[TBL] [Abstract][Full Text] [Related]
29. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
Ueshima S; Fukao H; Okada K; Matsuo O
Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
[TBL] [Abstract][Full Text] [Related]
30. Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.
Fibbi G; Pucci M; Grappone C; Pellegrini G; Salzano R; Casini A; Milani S; Del Rosso M
Hepatology; 1999 Mar; 29(3):868-78. PubMed ID: 10051491
[TBL] [Abstract][Full Text] [Related]
31. beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter.
Hapke S; Gawaz M; Dehne K; Köhler J; Marshall JF; Graeff H; Schmitt M; Reuning U; Lengyel E
Mol Cell Biol; 2001 Mar; 21(6):2118-32. PubMed ID: 11238946
[TBL] [Abstract][Full Text] [Related]
32. Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow.
Heiss MM; Simon EH; Beyer BC; Gruetzner KU; Tarabichi A; Babic R; Schildberg FW; Allgayer H
J Clin Oncol; 2002 Apr; 20(8):2005-16. PubMed ID: 11956259
[TBL] [Abstract][Full Text] [Related]
33. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
[TBL] [Abstract][Full Text] [Related]
34. Influence of urokinase on cell proliferation and invasion.
Binder BR
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):717-20. PubMed ID: 1966799
[TBL] [Abstract][Full Text] [Related]
35. CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review.
Béné MC; Castoldi G; Knapp W; Rigolin GM; Escribano L; Lemez P; Ludwig WD; Matutes E; Orfao A; Lanza F; van't Veer M;
Leukemia; 2004 Mar; 18(3):394-400. PubMed ID: 14671631
[TBL] [Abstract][Full Text] [Related]
36. Role of urokinase receptor and caveolin in regulation of integrin signaling.
Chapman HA; Wei Y; Simon DI; Waltz DA
Thromb Haemost; 1999 Aug; 82(2):291-7. PubMed ID: 10605716
[TBL] [Abstract][Full Text] [Related]
37. The plasminogen activation system in bovine milk: differential localization of tissue-type plasminogen activator and urokinase in milk fractions is caused by binding to casein and urokinase receptor.
Heegaard CW; Rasmussen LK; Andreasen PA
Biochim Biophys Acta; 1994 May; 1222(1):45-55. PubMed ID: 8186264
[TBL] [Abstract][Full Text] [Related]
38. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
[TBL] [Abstract][Full Text] [Related]
39. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
Guiducci S; Del Rosso A; Cinelli M; Perfetto F; Livi R; Rossi A; Gabrielli A; Giacomelli R; Iori N; Fibbi G; Del Rosso M; Cerinic MM
Arthritis Res Ther; 2005; 7(6):R1244-53. PubMed ID: 16277677
[TBL] [Abstract][Full Text] [Related]
40. Molecular regulation of urokinase-receptor gene expression as one potential concept for molecular staging and therapy.
Allgayer H
Recent Results Cancer Res; 2003; 162():15-30. PubMed ID: 12790318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
